BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 9, 2004
View Archived Issues
Serostim reduces visceral adipose tissue in HARS study
Read More
JNJ-7777120, a potent histamine H4 receptor antagonist with antiinflammatory activity
Read More
BMS describes novel, potent motilin agonist for treatment of GI hypomotility disorders
Read More
Efficacy of Menocare in management of menopausal symptoms
Read More
Par and Advancis to develop pulsatile amoxicillin
Read More
NexMed plans Chinese FSAD phase III study for Femprox
Read More
CytoGenix DNA antibacterial compound shows preclinical promise for sepsis
Read More
Alagebrium chloride approved as generic name for ALT-711
Read More
EMEA accepts Exubera filing
Read More
KOS-862 studied in combination with Gemzar for advanced solid tumors
Read More
Actiza NDA accepted for filing
Read More
Positive phase II results for BAL-5788
Read More
Nippon Shinyaku and Seikagaku terminate NS-7201 license agreement
Read More
Antigen Express to develop diagnostic kit for early detection of type 1 diabetes
Read More
Intrathecal Naropin recommended for approval in Europe
Read More
LifeSci Channel broadcasts ADA's 51st Postgraduate Course
Read More
Therapeutic antibodies with reduced side effects presented by Isis Innovation
Read More
Two novel series of SERM and their use reported by Lilly
Read More
Euroceltique claims new VR1/mGluR antagonists in a recent patent
Read More
AstraZeneca team develops new CXCR2 modulators for asthma, rhinitis, COPD, etc.
Read More
Aventis patent covers novel MCH receptor modulators for obesity and other uses
Read More
New antibacterial quinolines prepared and tested at Aventis
Read More
Novel anti-HIV agents in early development at BMS
Read More
Two series of sodium channel blockers discovered by Euroceltique scientists
Read More
FDA approval for Taxus Express2 stent
Read More
Adventrx files IND for BlockAide/CR phase Ib/IIa trials
Read More
LymphoStat-B selected for CMA Pilot 2 program
Read More
Positive results for MMH Malarex in comparative study with Camoquine
Read More
Kucera discovers novel antiviral compounds with potential for SARS
Read More
A new clinical trial to assess the efficacy and safety of RotaTeq(TM) against rotavirus infection
Read More
Antiretroviral efficacy of atazanavir plus enfuvirtide in HIV infection
Read More